Transcript: Gerson-style Therapy vs. Chemotherapy
The recent review dismissing Gerson therapy as useless or worse for the treatment of cancer was published before this landmark study came out, a head-to-head test of a Gerson-style regime versus the standard chemotherapy agent jemsitabean for pancreatic cancer, one of the deadliest of all malignancies. Being diagnosed with inoperable pancreatic cancer is basically, on average, being given a 6 month death sentence. The best modern medicine can offer is chemotherapy designed not to cure, but to just slow down the death process and give people a few extra months. Since death is essentially considered inevitable it offers an opportunity to try out untested therapies, because what’s the worst that can happen?
You’d think with all the interest in complementary and alternative medicine there’d be lots of these trials, but they’re actually exceedingly rare, and difficult to do. The National Cancer Institute and American Cancer Society should be commended for their efforts here.
So 55 patients, 23 chose chemo; 32 chose treatment with enzymes, supplements, detox and an organic diet, composed of mostly raw foods.
This may be among the “first controlled, clinical studies to compare allopathic—meaning standard medical—treatment to an alternative medicine program for a survival end point.” What did they find?
Well first of all, before they even started they agreed on what's called a "stopping rule." If one therapy started working way better than the other, then they’d just stop it because it would be unethical to continue. That point was reached and they had to stop the study prematurely because there were so many more deaths in the… Gerson therapy alternative group.
Here’s the survival curve. Here's the chemo group. As you can see, despite conventional medicine's best efforts, about half were dead in a year, but here's the enzyme and raw food group. As you can see they started dying off almost immediately, whereas those in chemo group tended to be able to hold out longer. Yeah but what about the quality of their lives in their last few months on earth? Quality of life was significantly better in the chemo group as well.
“Conclusion: Among patients who have pancreatic cancer, those who chose jemsitabean-based chemotherapy survived more than three times as long (14 months on average versus 4 months) and had better quality of life than those who chose proteolytic enzyme treatment.”
To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring watch the above video. This is just an approximation of the audio contributed by Kerry Skinner.
To help out on the site please email firstname.lastname@example.org